You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

shr-1210

Showing 26 - 46 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma Trial in Beijing (SHR-1210, Apatinib, Irinotecan Injection)

Unknown status
  • Esophageal Squamous Cell Carcinoma
  • SHR-1210
  • +4 more
  • Beijing, China
    Jing Huang
Feb 9, 2020

Locally Advanced or Metastatic and Unresectable HCC Trial in Worldwide (SHR-1210, Apatinib, Sorafenib)

Active, not recruiting
  • Locally Advanced or Metastatic and Unresectable HCC
  • SHR-1210
  • +2 more
  • Beverly Hills, California
  • +120 more
Dec 29, 2021

Esophageal Cancer Trial in Tianjin (SHR-1210)

Completed
  • Esophageal Cancer
  • SHR-1210
  • Tianjin, Tianjin, China
    Department of Radiation Oncology, Tianjin Medical University Can
Dec 2, 2019

Esophageal Carcinoma Trial in Beijing (SHR-1210, Docetaxel, Irinotecan)

Completed
  • Esophageal Carcinoma
  • SHR-1210
  • +2 more
  • Beijing, China
  • +1 more
Oct 23, 2019

Lung Cancer Stage II, PD-1 Antibody, NSCLC Trial (SHR-1210, Carboplatin and Paclitaxel-albumin)

Unknown status
  • Lung Cancer Stage II
  • +2 more
  • SHR-1210
  • Carboplatin and Paclitaxel-albumin
  • (no location specified)
Sep 26, 2019

Lung Diseases, Tumors, Respiratory Tract Diseases Trial in Chengdu (Apatinib, SHR-1210)

Unknown status
  • Lung Diseases
  • +4 more
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital
Oct 17, 2019

Hepatocellular Carcinoma Trial in Shanghai (SHR-1210, apatinib)

Unknown status
  • Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Jul 10, 2019

Metastatic Colorectal Cancer Trial in Guangzhou (SHR-1210, BP102, oxaliplatin)

Terminated
  • Metastatic Colorectal Cancer
  • SHR-1210
  • +3 more
  • Guangzhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University (CCSYSU)
May 8, 2019

Hodgkin Lymphoma Trial in Beijing (SHR-1210, Decitabine)

Recruiting
  • Hodgkin Lymphoma
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Mar 28, 2019

Advanced Esophageal Cancer Trial in Guangzhou (SHR-1210, Placebo, paclitaxel)

Unknown status
  • Advanced Esophageal Cancer
  • SHR-1210
  • +3 more
  • Guangzhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University (CCSYSU)
Mar 28, 2019

Solid Tumor Trial in Guangzhou (SHR7390, SHR-1210, SHR3162)

Unknown status
  • Solid Tumor
  • Guangzhou, Guangdong, China
    The Cancer Center,Sun Yat-sen University
Feb 25, 2019

Esophageal Squamous Cell Carcinoma Trial in Zhengzhou (SHR-1210, Placebo)

Unknown status
  • Esophageal Squamous Cell Carcinoma
  • SHR-1210
  • Placebo
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Jan 23, 2019

Esophageal Cancer Trial in Tianjin (SHR-1210, IMRT or VMAT, Apatinib)

Unknown status
  • Esophageal Cancer
  • SHR-1210
  • +2 more
  • Tianjin, Tianjin, China
    Department of Radiation Oncology, Tianjin Medical University Can
Jan 7, 2019

NSCLC Stage IV, KRAS Gene Mutation, PD-1 Antibody Trial (SHR-1210, Apatinib, Pemetrexed)

Unknown status
  • NSCLC Stage IV
  • +3 more
  • SHR-1210
  • +3 more
  • (no location specified)
Jan 17, 2019

Hepatocellular Carcinoma Trial in Shanghai (SHR-1210, apatinib)

Unknown status
  • Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Dec 16, 2018

Primary Mediastinal Large B-cell Lymphoma Trial in Beijing (Decitabine, GVD chemo, SHR-1210)

Unknown status
  • Primary Mediastinal Large B-cell Lymphoma
  • Beijing, Beijing, China
  • +1 more
Nov 29, 2018

CRC, HCC, NSCLC Trial (SHR-1210, SHR6390)

Unknown status
  • CRC
  • +2 more
  • (no location specified)
Jul 24, 2018

Gastric Cancer, Hepatocellular Carcinoma Trial in Beijing (apatinib, SHR-1210)

Unknown status
  • Gastric Cancer
  • Hepatocellular Carcinoma
  • Beijing, Beijing, China
    The Affiliated Hospital of the Chinese Academy of Military Medic
Feb 23, 2018

Non Small Cell Lung Cancer Trial in GuangZhou (Ipilimumab, SHR-1210)

Unknown status
  • Non Small Cell Lung Cancer
  • GuangZhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University (CCSYSU)
May 27, 2018

NSCLC Trial in Shanghai (SHR-1210, Apatinib)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Feb 6, 2018

Advanced Malignant Solid Tumor Trial in Nanjing (Neoantigen Reactive T Cells(NRTs), SHR-1210, Fludarabine)

Unknown status
  • Advanced Malignant Solid Tumor
  • Neoantigen Reactive T Cells(NRTs)
  • +4 more
  • Nanjing, Jiangsu, China
    The Comprehensive Cancer Centre of Drum Tower Hospital, Medical
Jun 2, 2017